Redcare Pharmacy N.V.
RDC
ISIN NL0012044747 / Valor 34117753
Redcare Pharmacy N.V.
UMushroom community rating:
About company
Redcare Pharmacy N.V. is a pharmaceutical company founded in 2001, with a focus on digitalizing healthcare systems. The company's leadership team includes individuals with extensive experience in finance, information technology, and commercial operations. The CEO, Olaf Heinrich, previously worked at an online pharmacy and has a deep understanding of the industry. The Chief Commercial Officer, Stephan Weber, has a background in pharmaceutics, while other key members bring expertise in management, IT, and business administration. Redcare Pharmacy N.V. aims to provide innovative solutions in the pharmaceutical sector through a combination of digital technologies and industry knowledge.
Summarized from source with an LLMView SourceSector: FinanceLatest Results (28.08.2026):
Redcare Pharmacy N.V. — Q2 2026: The company reports accelerated growth in Q2 2026, with a reported 20% revenue increase for the quarter, expanding EBITDA margins, and the international business turning profitable; management has raised full‑year 2026 guidance following these results.
Revenue
Q2 2026 revenue growth of 20% (as reported in the company release), described by management as a strong topline performance.
Profitability & margins
EBITDA margin is expanding in Q2 2026; the company also highlighted a prior update noting a 58% increase in adjusted EBITDA earlier in 2026.
International segment
The international operations are reported to have turned profitable in the period, contributing to overall margin expansion.
Guidance
Following the Q2 performance, Redcare Pharmacy N.V. raised its full‑year 2026 guidance (company statement dated 15/06/2026).
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1317 M
Market cap (USD)
81,821
Daily traded volume (Shares)
138.9 / 134.1
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Laura Prieto
Julia Jarosch
Nadja O
EQUITIES OF THE SAME SECTOR
